Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

711results about "Preparation by hydrocarbon ammoxidation" patented technology

Method for gas-solid contacting in a bubbling fluidized bed reactor

The present invention relates to a method for gas-solid contacting in a bubbling fluidized bed reactor by:(a) introducing into a reactor with bed length to bed diameter ratio below about 5.0, a primary gas consisting essentially of reactant(s) of the reaction to be carried out in the bed of solid particles through a primary gas distributor located at the reactor bottom at a superficial gas velocity Up, which is very close or equivalent to the minimum fluidization velocity Umf, required for achieving the incipient fluidization of the solid particles in the bed to obtain an emulsion phase consisting essentially of the solid particles and the primary gas with little or no formation of gas bubbles to achieve incipient fluidization or liquid-like behavior of fluidizable solid particles;(b) forming gas bubbles in the incipiently fluidized bed by introducing through a secondary gas distributor located immediately above the primary gas distributor a secondary gas, selected from one of the reactants which is used in excess of that required for the reaction stoichiometry, steam, an inert or a mixture of two or more thereof at a superficial gas velocity, Us, which is related to the superficial velocity of the primary gas such that a ratio of the superficial velocity of the secondary gas to the superficial velocity of the primary gas Us / Up, is in the range from about 0.5 to about 10.0, preferably from about 1 to about 5.
Owner:COUNCIL OF SCI & IND RES

Process for producing acrylonitrile or methacrylonitrile from propane or isobutane by ammoxidation

Process for producing acrylonitrile or methacrylonitrile from propane or isobutane by ammoxidation at a temperature in the range of from 380 to 500 DEG C. in a fluidized-bed reactor containing a catalyst composition preheated to a temperature of not lower than 300 DEG C. and lower than the ammoxidation reaction temperature, the catalyst composition comprising a carrier having supported thereon an oxide catalyst comprising a compound oxide of molybdenum, vanadium, niobium and at least one element selected from tellurium and antimony, wherein the ammoxidation of propane or isobutane is preceded by a specific temperature elevation operation in which the catalyst temperature in the reactor is elevated, while supplying into the fluidized-bed reactor a molecular oxygen-containing gas together with a combustible gas capable of combustion by reaction with the molecular oxygen in the presence of said catalyst composition, until the temperature of the catalyst composition reaches said ammoxidation reaction temperature. The process of the present invention is advantageous in that the temperature elevation of the catalyst can be performed without suffering a deterioration of the catalytic activity during the temperature elevation, thereby allowing the catalyst to fully exhibit its performance.
Owner:ASAHI KASEI KK

Prevention of tissue ischemia, related methods and compositions

Provided herein are compositions and methods for preventing, ameliorating, and / or reducing tissue ischemia and / or tissue damage due to ischemia, increasing blood vessel diameter, blood flow and tissue perfusion in the presence of vascular disease including peripheral vascular disease, atherosclerotic vascular disease, coronary artery disease, stroke and influencing other conditions, by suppressing CD47 and / or blocking TSP1 and / or CD47 activity or interaction. Influencing the interaction of CD47-TSP1 in blood vessels allows for control of blood vessel diameter and blood flow, and permits modification of blood pressure and cardiac function. Under conditions of decreased blood flow, for instance through injury or atherosclerosis, blocking TSP1-CD47 interaction allows blood vessels to dilate and increases blood flow, tissue perfusion and tissue survival. This in turn reduces or prevents tissue necrosis and death. The therapeutics identified herein allow for precise regulation of blood flow to tissues and organs which need it, while substantially avoiding systemic complications. Methods and compositions described herein can be used to increase tissue survival under conditions of trauma and surgery, as well as conditions of chronic vascular disease. Also disclosed are methods for the treatment of elderly subjects using agents that affect TSP1 and CD47 and thereby affect tissue perfusion. Additionally, provided herein are compositions and methods for influencing blood coagulation, allowing for controlled increased or decreased blood clotting. Additionally, provided herein are compositions and methods for decreasing blood flow, as in the case of cancer through mimicking the effects of TSP1 and CD47 on blood vessel diameter and blood flow.
Owner:WASHINGTON UNIV IN SAINT LOUIS +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products